The global COVID-19 vaccine surplus: tackling expiring stockpiles

BACKGROUND: A global surplus of coronavirus disease 2019 (COVID-19) vaccines exists as a result of difficulties in aligning the demand and supply for vaccine manufacturing and delivery. World leaders have accelerated vaccine development, approval, production and distribution as a pragmatic approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Nguyen Khoi, Anh, Nguyen Le My, Taylor-Robinson, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025780/
https://www.ncbi.nlm.nih.gov/pubmed/36941709
http://dx.doi.org/10.1186/s40249-023-01070-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025780/
https://www.ncbi.nlm.nih.gov/pubmed/36941709
http://dx.doi.org/10.1186/s40249-023-01070-7

Ejemplares similares